Next-Generation Robotic Clot Removal Systems

Publication ID: 24-11857277_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Robotic Clot Removal Systems,” Published Technical Disclosure No. 24-11857277_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857277_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,277.

Summary of the Inventive Concept

A next-generation robotic clot removal system that leverages advanced technologies such as swarm robotics, AI-powered autonomous clot detection, nanosecond-pulse laser systems, modular instrument modules, and hybrid robotic-human systems to revolutionize the field of clot removal.

Background and Problem Solved

The original patent disclosed a robotically controlled system for removing clots from patients, but it had limitations in terms of clot detection, removal efficiency, and adaptability to changing clot morphology. The new inventive concept addresses these limitations by introducing advanced technologies that enable more efficient, precise, and adaptable clot removal.

Detailed Description of the Inventive Concept

The new inventive concept comprises a swarm of micro-robots that can be injected into a patient's vasculature to collectively disintegrate and remove blood clots. The micro-robots are capable of real-time communication and coordination to optimize clot removal efficiency. Additionally, the system features a neural network-based AI system integrated with a robotic catheter, which analyzes real-time imaging data to identify clot locations and instruct the robotic catheter to perform targeted clot removal. The system also includes a nanosecond-pulse laser system that can be used to selectively disintegrate blood clots while preserving surrounding vasculature. The laser system is controlled by a robotic arm to ensure precise targeting and minimal tissue damage. Furthermore, the system features interchangeable instrument modules that can be swapped in and out depending on the specific clot removal procedure, allowing for real-time adaptation to changing clot morphology and composition. Finally, the system includes a hybrid robotic-human system, wherein a robotic arm assists a human operator in performing clot removal procedures, providing real-time haptic feedback and stabilization to enhance the operator's dexterity and precision.

Novelty and Inventive Step

The new claims introduce novel and non-obvious features such as swarm robotics, AI-powered autonomous clot detection, nanosecond-pulse laser systems, modular instrument modules, and hybrid robotic-human systems, which significantly improve the efficiency, precision, and adaptability of clot removal compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of micro-robots, such as those with different shapes or sizes, or incorporating additional sensors or imaging modalities to enhance clot detection and removal. Variations could also include using the system for removing clots in different parts of the body, such as the lungs or legs.

Potential Commercial Applications and Market

The next-generation robotic clot removal system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and neurovascular interventions. The system's advanced features and improved performance could make it an attractive option for hospitals and medical centers, potentially disrupting the existing market for clot removal devices.

CPC Classifications

SectionClassGroup
A A61 A61B34/30
A A61 A61B17/12136
A A61 A61B17/3207
A A61 A61B2017/22038
A A61 A61B2034/301
A A61 A61B2034/303
A A61 A61B2090/08021

Original Patent Information

Patent NumberUS 11,857,277
TitleRobotically controlled clot manipulation and removal
Assignee(s)Auris Health, Inc.